成都康弘药业集团股份有限公司关于完成工商变更登记及公司章程修订的公告

Core Viewpoint - Chengdu Kanghong Pharmaceutical Group Co., Ltd. has completed the registration of changes in its business license and the revision of its articles of association following the approval of relevant proposals at its board and annual shareholder meetings [1][2]. Group 1: Company Actions - The company held its eighth board meeting on April 25, 2025, and the annual shareholder meeting on May 21, 2025, where it approved the proposal to change the registered capital and revise the articles of association [1]. - The revised articles of association are published on the Giant Tide Information Network [1]. Group 2: Documentation - The following documents are available for review: the resolutions from the eighth board meeting, the resolutions from the 2024 annual shareholder meeting, and the revised articles of association as of May 2025 [2].